Children with neurological and neuromuscular diseases often present anesthetic problems in the perioperative period. The anesthetic technique can play a significant role in altering the state of the brain during neurosurgical procedures through effects on the cerebral circulation and metabolism. Pre-existing neuromuscular disease may also have specific anesthetic implications such as cardiorespiratory involvement (eg, myotonia dystrophica), the potential for drug interactions (eg, myasthenia gravis) or abnormal responses to commonly used drugs (eg, malignant hyperthermia). In this review, the perioperative anesthetic considerations in a number of common neurological and neuromuscular conditions in the pediatric patient are discussed. (J Child Neurol 1986;1:189-197)
Get full access to this article
View all access options for this article.
References
1.
Shapiro HM: Intracranial hypertension: therapeutic and anesthetic considerations . Anesthesiology1975;43:445-471.
2.
Hill A., Volpe JJ: Measurement of intracranial pressure using the Ladd intracranial pressure monitor. J Pediatr1981;98:974-976.
Grubb RL, et al: The effects of changes in PaCO2 on cerebral blood volume, blood flow, and vascular mean transit time. Stroke1974;5:630-639.
5.
Lassen NA: Control of cerebral circulation in health and disease. Circ Res1974;34:749-760.
6.
Harbaugh RD, et al: Acute therapeutic modalities for experimental vasogenic edema . Neurosurgery1979;5:656-665.
7.
Cottrell JE, et al: Furosemide- and mannitol-induced changes in intracranial pressure and serum osmolality and electrolytes. Anesthesiology1977;47:28-30.
8.
Samson D., Beyer CW: Furosemide in the intraoperative reduction of intracranial pressure in the patient with subarachnoid hemorrhage. Neurosurgery1982;10:167-169.
9.
Pollay M., et al: Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg1983 ;59:945-950.
10.
Eisenberg HM , Barlow CF, Lorenzo AV: Effect of dexamethasone on altered brain vascular permeability. Arch Neurol1970;23:18-22.
11.
Bedford RF , Winn HR, Park TS, Jane JA: Lidocaine prevents increased ICP after endotracheal intubation, in Shulman K, et al (eds): Intracranial Pressure IV. New York, Springer Verlag, 1980, 595-598.
12.
Shapiro HM, Galindo A., Wyte SR, Harris AB: Rapid intraoperative reduction of intracranial pressure with thiopentone . Br J Anaesth1973;45:1057-1062.
13.
Abou-Madi MN , Keszler H., Yacoub JM: Cardiovascular reactions to laryngoscopy and tracheal intubation following small and large intravenous doses of lidocaine . Can Anaesth Soc J1977 ;24:12-19.
14.
Cronin MM, Bousfield JD, Hewett EB, et al: Ketamine anaesthesia for radiotherapy in small children. Anaesthesia1972;27:135-142.
15.
Maltby JR, Watkins DMB: Repeat ketamine anaesthesia of a child for radiotherapy in the prone position . Can Anaesth Soc J1983;30:526-530.
16.
Wong DHW , Jenkins LC: An experimental study of the mechanism of action of ketamine on the central nervous system. Can Anaesth Soc J1974;21:57-67.
17.
Idvall J., Ahlgren I., Aronsen KF, Stenberg P.: Ketamine infusions: Pharmacokinetics and clinical effects. Br J Anaesth1979;51:1167-1172.
18.
White PF, Way WL, Trevor AJ: Ketamine—its pharmacology and therapeutic uses. Anesthesiology1982;56:119-136.
19.
Soliman MG, Brindle GF, Kuster G.: Response to hypercapnia under ketamine anaesthesia. Can Anaesth Soc J1975;22:486-494.
20.
Sussman DR: A comparative evaluation of ketamine anesthesia in children and adults . Anesthesiology1974;40:459-464.
21.
Kothary SP, Zsigmond EK: A double-blind study of the effective antihallucinatory doses of diazepam prior to ketamine anesthesia. Clin Pharmacol Ther1977;21:108-109.
22.
Meyers EF, Charles P.: Prolonged adverse reactions to ketamine in children. Anesthesiology1978;49:39-40.
23.
Gardner AE, Olson BE, Lichtiger M.: Cerebrospinal-fluid pressure during dissociative anesthesia with ketamine . Anesthesiology1971;35:226-228.
24.
Crumrine RS , Nulsen FE, Weiss MH: Alterations in ventricular fluid pressure during ketamine anesthesia in hydrocephalic children. Anesthesiology1975;42:758-761.
25.
Eger EI: Isoflurane: A review. Anesthesiology1981;55:559-576.
26.
Adams RW, Gronert GA, Sundt TM, Michenfelder JD: Halothane, hypocapnia, and cerebrospinal fluid pressure in neurosurgery . Anesthesiology1972;37:510-517.
27.
Miletich DJ , Ivankovich AD, Albrecht RF, et al: Absence of autoregulation of cerebral blood flow during halothane and enflurane anesthesia . Anesth Analg1976;55:100-106.
28.
Adams RW, Cucchiara RF, Gronert GA, et al: Isoflurane and cerebrospinal fluid pressure in neurosurgical patients. Anesthesiology1981;54:97-99.
29.
Newberg LA, Michenfelder JD: Cerebral protection by isoflurane during hypoxemia or ischemia. Anesthesiology1983;59:29-35.
30.
Casement B. , Messick J., Milde L., et al: Critical rCBF during isoflurane anesthesia in man. Anesthesiology1983;63:A406.
31.
Lam AM, Gelb AW: Cardiovascular effects of isoflurane-induced hypotension for cerebral aneurysm surgery. Anesth Analg1983;62:742.
32.
McPherson RW , Mahla M., Traystman RJ: Effects of anesthetic gases on somatosensory evoked potentials during narcotic anesthesia. Anesthesiology1983;59:A319.
33.
Peterson DO , Drummond JC, Todd MM: Effects of halothane and isoflurane on somatosensory evoked potentials in man. Anesthesiology1984 ;61:A344.
34.
Pathak KS, Amaddio BS, Shaffer JW, Scoles PV: Effect of halothane, nitrous oxide anesthesia on spinal versus cortical evoked potentials during spinal surgery. Anesthesiology1984;61:A346.
35.
Pathak KS, Brown RH, Cascorbi HF, Nash CL: Effects of fentanyl and morphine on intraoperative somatosensory cortical-evoked potentials. Anesth Analg1984;63:833-837.
36.
Mori K., Murata T., Hashimoto N., Handa H.: Clinical analysis of arteriovenous malformations in children. Childs Brain1980;6:13-25.
37.
So SC: Cerebral arteriovenous malformations in children. Childs Brain1978;4:242-250.
38.
McLeod ME , Creighton RE, Humphreys RP: Anaesthesia for cerebral arteriovenous malformations in children. Can Anaesth Soc J1982;29:299-306.
39.
stergaard JR , Voldby B.: Intracranial arterial aneurysms in children and adolescents. J Neurosurg1983;58:832-837.
40.
Storrs BB, Humphreys EB, Hoffman HJ: Intracranial aneurysms in the pediatric age-group. Childs Brain1982;9:358-361.
41.
Amacher AL, Drake CG: The results of operating upon cerebral aneurysms and angiomas in children and adolescents. Childs Brain1979;5:151-165.
42.
Szabo M., Crosby G., Sundaram P., et al: Intracranial arteriovenous malformations: Does hypertension cause spontaneous hemorrhage?Anesthesiology1985;63:A399.
43.
Maktabi M., Warner D., Boarini D., et al: A comparison of nitroprusside and deep isoflurane anesthesia for induced hypotension. Anesthesiology1985 ;63:A403.
44.
Oliver A.: Surgical management of complex partial seizures, in Epilepsy: An Update on Research and Therapy. New York, AR Liss Inc, 1983, pp 309-324.
45.
Fisher RS, Uematsu S.: Surgical therapy of complex partial epilepsy. Johns Hopkins Med J1982;151:332-343.
46.
Blume WT, Grabow JD, Darley FL, Aronson AE: Intracarotid amorbarbital test of language and memory before temporal lobectomy for seizure control. Neurology1973 ;23:812-819.
47.
Ford EW, Morrell F., Whisler WW: Methohexital anesthesia in the surgical treatment of uncontrollable epilepsy . Anesth Analg1982;61:997-1001.
48.
Musella L., Wilder BJ, Schmidt RP: Electroencephalographic activation with intravenous methohexital in psychomotor epilepsy. Neurology1971;21:594-602.
49.
Rasmussen T. : Cortical resection in the treatment of focal epilepsy. Adv Neurol1975;8:139-154.
50.
Reigel DH: Spina bifida, in Paediatric Neurosurgery. New York, Grune & Stratton, 1982, pp 23-47.
51.
Park TS, Hoffman HJ, Hendrick EB, Humphreys RP: Experience with surgical decompression of the Arnold-Chiari malformation in young infants with myelomeningocele. Neurosurgery1983;13:147-152.
52.
Seiben RL, Hamida MB, Shulman K.: Multiple cranial nerve deficits associated with the Arnold-Chiari malformation . Neurology1971;21:673-681.
53.
Drachman DB : Myasthenia Gravis. N Engl J Med1978;298:136-142.
54.
Foldes FF, McNall PG: Myasthenia gravis: A guide for anesthesiologists. Anesthesiology1962;23:837-872.
55.
Millichap JG , Dodge PR: Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescence. Neurology1960;10:1007-1014.
56.
Rolbin SH, Levison G., Shnider SM, Wright RG: Anesthetic considerations for myasthenia gravis and pregnancy. Anesth Analg1978;57:441-447.
57.
Miller J., Lee C.: Muscle diseases, in Katz J, et al (eds): Anesthesia and Uncommon Diseases. Philadelphia, WB Saunders Co, 1981 .
58.
Bell CF, Florence AM, Hunter JM, et al: Atracurium in the myasthenic patient. Anaesthesia1984;39:961-968.
59.
Ward S., Wright DJ: Neuromuscular blockade in myasthenia gravis with atracurium besylate . Anaesthesia1984;39:51-53.
60.
Levanthal SR , Orkin FK, Hirsh RA: Predicting postoperative ventilatory need in myasthenia. Anesthesiology1979;61:S151.
Walton JN, Gardner-Medwin D: Disorders of Voluntary Muscle. New York , Churchill Livingstone, 1981.
63.
Vanier TM: Dystrophia myotonica in childhood. Br Med J1960;2:1284-1288.
64.
Harper PS: Congenital myotonic dystrophy in Britain. Arch Dis Child1975;50:505-513.
65.
Motta J., Guilleminault C., Billingham M., et al: Cardiac abnormalities in myotonic dystrophy. Am J Med1979;67:467-473.
66.
Gottdiener JS, Hawley RJ, Gay JA, et al: Left ventricular relaxation, mitral valve prolapse, and intracardiac conduction in myotonia atrophica. Am Heart J1982;104:77-85.
67.
Meyers MB, Barash PG: Cardiac decompensation during enflurane anesthesia in a patient with myotonia atrophica. Anesth Analg1976;55:433-434.
68.
Mitchell MM , Ali HH, Savarese JJ: Myotonia and neuromuscular blocking agents . Anesthesiology1978;49:44-48.
69.
Bray RJ, Inkster JS: Anaesthesia in babies with congenital dystrophia myotonica. Anaesthesia1984;39:1007-1011.
70.
Muller H., Punt-van Manen J.: Maxillo-facial deformities in patients with dystrophia myotonica and the anaesthetic implications. J Maxillofac Surg1982;10:224-228.
71.
Thiel RE: The myotonic response to suxamethonium. Br J Anaesth1967;39:815-820.
72.
Azar I.: The response of patients with neuromuscular disorders to muscle relaxants . Anesthesiology1984;61:173-187.
73.
Geschwind N. , Simpson JA: Procaine amide in the treatment of myotonia . Brain1955;78:81-91.
74.
Buzello W., Krieg N., Schlickewei A.: Hazards of neostigmine in patients with neuromuscular disorders. Br J Anaesth1982;54:529-534.
75.
Drennan JC : Progressive muscular dystrophy, in Orthopaedic Management of Neuromuscular Disorders. Philadelphia , JB Lippincott, 1983.
76.
Frankel KA, Rosser RJ: The pathology of the heart in progressive muscular dystrophy: Epimyocardial fibrosis. Hum Pathol1976;7:375-386.
77.
Sanyal SK, Johnson WW: Cardiac conduction abnormalities in children with Duchenne's progressive muscular dystrophy: Electrocardiographic features and morphologic correlates . Circulation1982;66:853-863.
78.
Sanyal SK, Leung RKF, Tierney RC, et al: Mitral valve prolapse in children with Duchenne's progressive muscular dystrophy. Pediatrics1979;63:116-123.
79.
Inkley SR, Oldenburg FC, Vignos PJ: Pulmonary function in Duchenne muscular dystrophy related to stage of disease . Am J Med1974;56:297-306.
80.
Richards WC : Anaesthesia and serum creatine phosphokinase levels in patients with Duchenne's pseudohypertropic muscular dystrophy. Anaesth Intensive Care1972;1:150-153.
81.
Cobham IG, Davis HS: Anesthesia for muscular dystrophy patients. Anesth Analg1964;43:22-29.
82.
Linter SPK , Thomas PR, Withington PS, Hall MG: Suxamethonium associated hypertonicity and cardiac arrest in unsuspected pseudohypertrophic muscular dystrophy. Br J Anaesth1982;54:1331-1332.
83.
Miller ED, Sanders DB, Rowlingson JC, et al: Anesthesia-induced rhabdomyolysis in a patient with Duchenne's muscular dystrophy. Anesthesiology1978;48:146-148.
84.
Seay AR, Ziter FA, Thompson JA: Cardiac arrest during induction of anesthesia in Duchenne muscular dystrophy . J Pediatr1978;93:88-90.
Brownell AKW , Paasuke RT, Elash A., et al: Malignant hyperthermia in Duchenne muscular dystrophy. Anesthesiology1983;58:180-182.
87.
Ronsenberg H. , Heiman-Patterson T.: Duchenne's muscular dystrophy and malignant hyperthermia: Another warning. Anesthesiology1983;59:362.
88.
Jenkins JG , Bohn D., Edmonds JF, et al: Evaluation of pulmonary function in muscular dystrophy patients requiring spinal surgery. Crit Care Med1982 ;10:645-649.
89.
Milne B., Rosales JK: Anaesthetic considerations in patients with muscular dystrophy undergoing spinal fusion and Harrington rod insertion. Can Anaesth Soc J1982;29:250-253.
Britt BA: Malignant hyperthermia. Can Anaesth Soc J1985; 32:666-677.
92.
Schwartz L. , Rockoff MA, Koka BV: Masseter spasm with anesthesia: incidence and implications. Anesthesiology1984;61:772-775.
93.
Flewellen EH , Nelson TE: Masseter spasm induced by succinylcholine in children: Contracture testing for malignant hyperthermia. Report of six cases. Can Anaesth Soc J1982;29:42-49.
94.
Donlon JV, Newfield P., Sreter F., Ryan JF: Implications of masseter spasm after succinylcholine. Anesthesiology1978;49:298-301.
95.
Larach MG, Rosenberg H.: Evaluation and management of pediatric patients for diagnostic muscle biopsy for malignant hyperthermia susceptibility. Anesthesiology1983;59:A228.
96.
Gronert GA, Milde JH: Variations in onset of porcine malignant hyperthermia. Anesth Analg1981;60:499-503.
97.
Jones DE, Ryan JF, Taylor B., et al: Pancuronium in large doses protects susceptible swine from halothane induced malignant hyperthermia. Anesthesiology1985;63:A344.
